Cochlear Implantation in Inner Ear Malformations

Abstract

Introduction: Cochlear Implantation (CI) has proven to be an effective treatment for severe bilateral Sensorineural Hearing Loss (SNHL). Inner ear malformation is a rare anomaly and occurs in approximately 20% of cases with congenital SNHL. There are particular challenges in the implantation of malformed cochleae, such as in cases of facial nerve anomalies, Cerebrospinal Fluid (CSF) leaks or facial stimulation, and the outcomes may differ depending on the severity of the malformation. The aim of this study was to assess the impact of Inner Ear Malformations (IEMs) on surgical complications and outcomes of cochlear implantation. Methods: Between 2018 and 2022, 9 patients with inner ear malformations were implanted in our department and completed at least 1 year of follow-up. The age range was between 2 years and 4 months and 5 years (average, 3.36 yr). Auditory performance, receptive and expressive language skills, and production and use of speech were evaluated preoperatively and at least 1 year after implantation. Results: In the study group, the most common malformation was an isolated Enlarged Vestibular Aqueduct (EVA) (55,5%). Overall, the patients with IEMs showed significant improvement in auditory-verbal skills. In general, the patients who had normal cochleae scored significantly better compared to patients with IEMs. Conclusion: Based on these findings, cochlear implantation is surgically feasible in patients with common cavity, IP types I and II, and EVA. The surgeon should be ready to make modifications in the surgical approach because of the abnormal course of the facial nerve and be ready to produce special precautions to cerebrospinal fluid gusher. Patients with EVA were the best performers in terms of auditory-verbal skills.